Novavax Inc. Stock Rises Thursday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) rose 2.18% to $16.85 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.13% to 11,482.45 and the Dow Jones Industrial Average falling 0.56% to 34,395.01. Novavax Inc. closed $219.65 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.42% to $178.74, Pfizer Inc. (PFE) rose 1.90% to $51.08, and Merck & Co. Inc. (MRK) fell 0.29% to $109.80. Trading volume (4.4 M) remained 932,660 below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2022.
(END) Dow Jones Newswires
December 01, 2022 17:23 ET (22:23 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.